Mazumdar-Shaw’s Mission to Expand Access to Life-Saving Drugs

Kiran Mazumdar-Shaw founded Biocon in a rented garage approximately 50 years ago, building it into a multibillion-dollar company that produces insulin and biosimilars. In an interview with Bloomberg, Mazumdar-Shaw discussed her career as an entrepreneur in India, her company's focus on delivering therapies to patients, and India's approach to artificial intelligence.

Next story